Lawyers claim that Sam Bankman-Fried needs extra Adderall to concentrate throughout the trial.
Attorneys representing the co-founder of FTX have raised a unique query: Can he be granted access to long-acting medication for ADHD? The reason for this request is his struggle to maintain proper concentration during his ongoing trial . Sam Bankman-Fried, the co-founder of FTX, has made a plea to a U.S. judge, seeking permission to use extended-release Adderall. He’s expressed difficulties in maintaining focus during the proceedings of his criminal trial. In a letter dated October 15, addressed to Judge Lewis Kaplan of the New York District, Bankman-Fried’s legal team has asked for approval to administer a “12-hour extended-release 20mg dose of Adderall” prior to his trial on October 16. They further elaborated that the absence of the prescribed stimulant during trial hours has substantially impeded his ability to concentrate at his usual level. With the impending defense phase and the decision on whether he will testify looming, concerns have arisen that the...